This company seems to have been delisted
Reason: Acquired by GHO and Ampersand
Last recorded trade on: April 10, 2025
Source: https://pharmasource.global/content/news/cdmo-news/avid-bioservices-acquired-by-gho-and-ampersand/
Reason: Acquired by GHO and Ampersand
Last recorded trade on: April 10, 2025
Source: https://pharmasource.global/content/news/cdmo-news/avid-bioservices-acquired-by-gho-and-ampersand/
Avid Bioservices
CDMO
C$17.16
Share price
0.00%
Change (1 day)
68.48%
Change (1 year)
Categories
Avid Bioservices (CDMO) Fails to deliver data
Key failure to deliver metrics for Avid Bioservices :
- Last SEC data release: 2025-06-30
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: N/A
- Last year FTD volume: N/A
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Avid Bioservices (CDMO) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Avid Bioservices (CDMO) - since 2018
Volume in USD (price x number of shares), data since 2018Avid Bioservices (CDMO) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | C$3.3 M | -77.48% |
| 2024 | C$14.68 M | 107.1% |
| 2023 | C$7.08 M | 41.5% |
| 2022 | C$5.01 M | -60.41% |
| 2021 | C$12.65 M | 1079.88% |
| 2020 | C$1.07 M | 90.18% |
| 2019 | C$0.56 M | -44.76% |
| 2018 | C$1.02 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Natera NTRA | C$8.52 M | C$15.33 M | 🇺🇸 USA |
 Neogen NEOG | C$9.9 M | C$19.32 M | 🇺🇸 USA |